>> joe? >> option monster has been highlighting activity in the agriculture sector. >> who was the first president of the united states? >> it wasn't ab raraham lincoln. george washington, sir. >> you got it right. "power lunch" begins now. indeed we do get started on "power lunch." i'm sue herera with bob pisani at the new york stock exchange. we have a rebound in the market right now, up 84 points after yesterday's big drop. the s&p is up about 16 points on the trading session. the biggest winner, though, is the nasdaq, 1.5% move, which is why you saw seema mody at the top of the show. she's the lead today up in times square. over to you. >> good afternoon. yeah, talk about a comeback. you will see right behind me, it is green across the screen. the nasdaq witnessing its best day in two months and what's interesting about this is that some of yesterday's laggards are

today's winners. take a look at some of the big names in biotech, staging a comeback. biogen, among others, leading the nasdaq 100 higher and speaking of health care, you got to take a look at intuitive surgical. intuitive surgical shares, the best performing stock on the nasdaq 100 after its preliminary fourth quarter revenue beat street estimates. then switch over to tech, because tech is the best performing s&p sector providing market leadership. google, expedia, apple, yahoo! broad-based gains in tech. tech is a sector favored to move higher in a rising rate environment. lastly, social media, those stocks have had a couple volatile days. we are seeing facebook, twitter among others posting gains. sue? >> thank you very much, seema. the trading action here, we are just off the highs of the trading session but the big event in today's trading session is two hawks on the fed are making comments. richard fisher will make comments shortly but mr. plosser

has made some comments and is talking about perhaps aggressive moves on interest rates in the near future. i am very surprised this market has been able to hold on to its advances. >> remember yesterday, there were comments as well from a more moderate feb member of the fomc. future rate increases may have to be aggressive. now, those are mr. prosser's words. he also said the tepid december jobs data was just one month's data so they are viewing it, he's yug it as-- viewing it as statistical fluke. the main argument of the hawks is we've gotten as much as we can from qe. nothing different, simply reiterating the position. i just want to note, we had a nice move to the upside right at the open, then sold off, they took some profits and the market didn't drop much. that's one of the things holding the market up here.

the overall market. with jpmorgan and wells fargo, we got earnings report exactly in line with expectations. it was remarkable because these are very hard to get right. jpmorgan and wells fargo, the numbers in line. you can see very minimal moves in both those stocks as well as the rest of the bank earnings. overall, we had a day where a lot of the beaten-up sectors like commodity etfs did very well. we noted how weak the oil etfs have been like xop this year and steel and coal stocks, all of them like the xme as well, another group, all weak this year on concerns about china and lower oil rates, all of them doing a little better today. so a little bit of reversal. the volume has just disappeared. we had good volume yesterday. all of a sudden today, much weaker volume. we don't have a lot of selling, it's easy for the markets to be on the upside. >> that's right. we're up 82 points. back up to e.c. and ty. let's go and connect with phil lebeau, who is on the phone to fill us in on a developing story, two, in fact.

one regarding boeing, the other regarding tesla. phil, take it away. your choice as to which you hit first. >> reporter: we will start with tesla. in fact, i'm standing right here at the tesla booth at the detroit auto show. here's the story. keep in mind that the recall that is driving the stock, this information is not new. in fact, we reported on it, many of us reported on it friday. what's changed is that tesla has filed paperwork with the federal government saying the battery charger, the adapters in garages for tesla owners, they have done a software update and will be sending new adapters to owners. tesla announced this on friday. they filed the paperwork with the federal government. it immediately went into the column of a recall. tesla has come out and said this is not a recall, we are not telling people to bring their car into the shop. this is an over the air software update as well as a change with the adapter, as a result it

shouldn't be considered a recall. that issue over semantics is part of the story, but the reason you're seeing the stock move higher today is a separate story. tesla has announced that it is raising its guidance for the fourth quarter, that its revenue will be 20% higher than previously expected, and that sales and delivery of the model s in the fourth quarter will total $6900 as opposed to the previous guidance which was $6,000. that's why you have shares of tesla moving higher in the midst of this debate over whether or not this is actually a recall from this information announced last week. as for boeing, the story here involves the 787 dreamliner. another dreamliner has had an issue with the lithium ion battery. this time it was a japan airlines dreamliner that was parked at a gate, no passengers on board, nobody involved, but during a maintenance check, white smoke was discovered coming from the fuselage. there was a battery malfunction

light that had come on within the plane. they saw that one of the eight cells in that lithium ion battery pack in the dreamliner had failed. boeing is aware of this. boeing is investigating what exactly happened, what caused this failure. boeing is also pointing out, and they are correct in this fashion, the redesigned battery packs are made to ensure that there is not a larger fire and that if one of the cells malfunctions, breaks down, that you then have it contained. so those are the two stories we have been tracking. a busy day. >> thank you very much, phil lebeau, from detroit. he's at the auto show but covering boeing as well. sue, let's resume with you at the nyse. we'll be watching those two stocks as this session continues. first, let's get some advice for this market from the bull in the market, jerry castellini and a somewhat bearish craig columbus,

chief market strategist at first allied asset management. i will start with you, craig, if i could. we spoke to you just shortly after thanksgiving and you had turned decidedly cautious on this market, and that was the correct call because we have had a very difficult start so far to this new year. but we're also seeing some resilience in this market. is it too soon for people to get back in? >> i think we can go higher, sue, but my concern was that many were underestimating the volatility that will come from transitioning simultaneously to new fed policy and new fed leadership at the same time, and i still have that concern. >> jerry, you are still bullish. how much more do you think this market has in it, and what are the characteristics of any further advance going to be? >> first of all, the market has a lot longer to go. by most measures, we are still midway through the economic cycle and it gives us a lot of earnings underneath us to drive the market, maybe even 20% higher this year.

the big difference, though, this year is going to be the type of names that you're going to need to look at. last year it was very defensive driven. it was dividend and share purchase names. this year, you're going to see an explosion in growth names. that's the exciting part. that's the part of the market cycle that most investors enjoy the most because you're back to names that have unique stories. that's what we haven't yet seen. it's really exciting. >> so craig, jerry is very excited, he's given us some places to play this market. where would you be deploying cash? >> i think you can be opportunistic and i agree, i like tech and industrials a lot. i think we have an aging durable goods stock and capex tracks ism manufacturing very closely with a lag. we have seen the manufacturing pick up. now we should see the cap ex pick up as well. >> thank you very much, gentlemen. appreciate it. ty, up to you. >> thank you very much. opportunities present themselves, it says right here, in many ways. dominic chu and sarah eisen have been talking to several analysts today and have been waiting

patiently for hours for this, right? they just arrived on set. about how the minimum wage is rising and how that could affect certain stocks and sectors. sarah, you are up. the last time we saw minimum wage hikes, which sectors moved for the better? >> well, consumer names and low income consumer names in particular. first, we should talk about the minimum wage hikes. it's happening across 14 different states in 2014. we are not seeing any action from congress or the federal government, but the states are taking this issue on on their own. if you look at which states are actually moving here this year, some of the most populous states, california, new york, new jersey is seeing the biggest in terms of percentage -- >> have to pay more for traffic control. >> yes, perhaps that's part of it. seriously, this could affect business. we have an analyst at rbc that covers these consumer staples who says look toward tobacco companies that could get a boost from this, beer companies and energy drinks. he says these are the companies

specifically that tend to boost when the low income earner has more money in their pocket to take home. those are some industries to watch here. it is a hot button issue. it's a political hot potato. that's why perhaps we haven't seen any traction federally since back in 2009. just today, a group of prominent economists weighed in, including seven nobel laureates saying minimum wage increase, they are talking about at the federal level, could have a small stimulative effect on the economy and for this reason, low wage workers spend their additional earnings providing some help on the job front as well. you know, though, you have been following this issue, many economists would disagree. >> there's a counter argument there. >> but look, the states are doing it and that will be a good place to see the evidence on business and the economy. >> i know someone standing right over there who would make that counter argument, michelle caruso-cabrera. she will join us in a moment. that's a whole other debate. but you will take us down a little deeper and look at individual names. >> sara mentioned the rbc capital markets. >> no relation to seema.

>> may be some kind of distant capacity. check this out. nick mody says the biggest beneficiary in the increase in low income income is their top tobacco pick, lorillard, america's biggest maker of menthol cigarettes. he says they generate a meaningful portion of sales and profit from new york and california, where tobacco consumption is highest and they are getting that increase in minimum wage. other ways to look at increase in income is the trade-up effect, the substitution effect. consumers get more cash and spend it on relatively higher priced premium products. mark schwartzman has mentioned this in the past with traditional carbonated sodas or juice to water products, often coca cola or pepsi already have products people would trade up to, like going from diet pepsi to trop 50. you can take that logic, apply it to other parts of the market so do folks buyer lower priced beers, do they end up trading up to a budweiser or coors, even

corona or becks? constellation brands have the distribution rights. on the restaurant side of things, it could mean folks that dine at burger king trade up. think applebee's or maybe chili's or even an olive garden or red lobster owned by darden restaurants. with sara, those concepts take effect kind of like what the economists were saying in their letter to president obama and the administration. >> isn't there an argument to the other side here that while lower income people might see some income boost, and they would spend more on convenience foods and so on and so forth, that some of those very providers of those products would be hurt because they would have labor cost increases? >> good point. >> when you talk about this minimum wage and the impact on business, usually you hear the negative impact on some of the big fast food companies. >> labor costs. >> mcdonald's, because the labor costs are going up, it will make it very difficult. two companies to watch actually could be, and you look at geographical exposure, monster

beverage in california, cheesecake factory in california. when you have a great portion of the income in sales coming from california, and you see their minimum wage going up from $8 to $9 in july, that could hurt those companies. >> cheesecake factory has great portions. let's make that clear. some said i looked like babe ruth last night. >> i think that's a compliment. >> swing for the fences. >> i had a better year than babe ruth. all right. higher mortgage rates, tight credit, weaker than expected demand for housing pushed mortgage origination volume down at the end of 2013. that has bankers revising their estimates down for 2014. diana olick is covering the story from washington. >> reporter: wells fargo, the leader by volume in home loans, saw a 60% drop in originations in q-4 from a year ago. they did $50 billion in originations in the quarter. jpmorgan not much better, down 54% to $35 billion in

originations. both were down on an annual and quarterly basis. refinance volume has been hit the hardest thanks to the higher rates but mortgage purchase applications have also been way down, off 16% last week from the same week a year ago, according to the mortgage bankers association. now, the mba today lowered its 2014 forecast for originations by $57 billion to $1.12 trillion for the year. it's not just the refis. they lowered their purchase originations by $34 billion to $677 billion. they cite not just higher rates but those new lending rules we keep talking about. of course, lots more online. sue? >> let's go back to dom with the market flash. >> we have to talk about intercept pharmaceuticals moving again, this time down another 32%. you need a steel stomach if you want to invest in this stock. it's been a roller coaster. last week it gained 550% on positive data for its treatment of a liver disease in a midstage trial but it's also been falling

ever since news came out that cholesterol levels may have been raised in that trial, so if you want to invest in intercept pharmaceuticals, you got to be ready for what could be a very big roller coaster ride. sue, back to you. >> thank you very much. french president francois hollande facing the fire in paris today. michelle is monitoring. >> he is fighting a lot of fires. he sounded like a red meat republican capitalist today. i will tell you what he said about the affair after the break. sue, back to you. >> also on the radar today, big news on an army of cyberfighting stocks. is this an opportunity for you and your money? we'll talk about that. there's a saying around here, you stand behind what you say. around here you don't make excuses. you make commitments. and when you can't live up to them, you own up, and make it right. some people think the kind of accountability that thrives on so many streets in this country

has gone missing in the places where it's needed most. but i know you'll still find it when you know where to look. anncr vo: introducing the schwab accountability guarantee. if you're not happy with one of our participating investment advisory services, we'll refund your program fee from the previous quarter. while, it's no guarantee against loss and other fees and expenses may still apply, we stand by our word. if you have a business idea, we have a personalized legal solution that's right for you. with easy step-by-step guidance, we're here to help you turn your dream into a reality. start your business today with legalzoom.

ask me what it's likeou turn your dream into a reality. to get your best night's sleep every night. [announcer] why not talk to someone who's sleeping on the most highly recommended bed in america? ask me about my tempur-pedic. ask me how fast i fall asleep. ask me about staying asleep. [announcer] tempur-pedic owners are more satisfied than owners of any traditional mattress brand. tempur-pedic. the most highly recommended bed in america. now sleep cooler with extra cooling comfort on our bestselling tempur-breeze beds. visit tempurpedic.com to learn more, and find a retailer near you. it took a lot of juggling to keep it all together.k. for some low-income families, having broadband internet is a faraway dream. so we created internet essentials, america's largest low-cost internet adoption program. having the internet at home means she has to go no further than the kitchen table to do her homework. now, more than one million americans have been connected at home. it makes it so much better to do homework, when you're at home. welcome to what's next. comcastnbcuniversal.

welcome back to "power lunch." the s&p 500 is having its best day in almost a month. right now you can see, up about .9%, 16 points to the upside. leading the index higher, regeneron, which will report about $1.4 billion in u.s. sales of its high profile eye drug for the year. its ceo saying there's lots of room for future growth. also intuitive surgical which issued fiscal year guidance above street estimates and jabil circuit which was added to the buy list. tyler? france's president francois hollande facing le media today amid a firestorm surrounding his private life, claims of an affair with an actress. michelle? >> that's good.

the french president says quote, private matters should remain private to a crowd of some 600 french and foreign journalists who gathered at the palace in paris, which just wrapped up five minutes ago. those comments came during a more than two and a half hour news conference which was supposed to be about hollande's new economic plan for france. in fact, the french president talked about cutting taxes and cutting red tape. big news in and of itself for the socialist president. that, he did for the first 50 minutes of the event but when the q & a started, the very first reporter question was about this woman, the status of valerie thrierweiler. she lives with him, has an office, a chauffeur and advisor all at taxpayer expense and the question was simple. is valerie thrierweiler still the first lady of france. hollande says private matters should remain private and this is neither the time nor the place to answer these questions. however, he also said he will clarify her status before a planned visit to washington, d.c. next month. so that leads to a whole lot of drama. who is he going to take to the

u.s. for the state visit? is it going to be the 49-year-old miss thrierweiler or the 41-year-old french actress julia gayet, the woman taken in secret photos at an apartment in paris, where the president was seen arriving as well in a helmet on the presidential scooter. >> the president goes on a scooter. can you imagine that in this country? >> he's a man of the people. >> michelle, thank you. stay on this story, will you? we have some breaking news. we will check in with steve liesman. >> reporter: fed president richard fisher, a new voter this year, taking the unusual step of pledging his vote to continue supporting tapering this year. in a speech that he's giving today, he says quote, as soon as feasible, we should change tack, we should stop digging. quote, i plan to cast my votes at fomc meetings accordingly. er gn to say he would support a taper even in the face of a stock market correction. and will support the taper as long as the economy is doing

reasonably well. it's growing, unemployment is falling and the deflation risk is small. he does not see a bubble in stocks or bonds. he goes on to say that he's warning of signs of quote, conspicuous consumption, however, from the stock and bond markets. and he's concerned about inflation and financial stability from the excess reserves that the fed has put out in the system now, four trillion of them right now. he's worried the fed may face criticism giving money to banks in order to keep those excess reserves in check and this criticism may ultimately hinder its policy making. meanwhile, in the wake of two upbeat reports this morning, the retail sales report and the inventory reports, economists have been upgrading their forecast for the fourth quarter. we just want to show you, cnbc did a survey of ten economists. right now, the fourth quarter coming in at 3.4%, up .3 from the last time we did this last week, and the second half now, guys, running at 3.7. there's the data this morning.

retail sales and autos up 0.7, inventories up. there's the estimates that we have calculated from ten economists with a little help from moody's. so the second half estimate, that's the second best second half that we have had or second best -- second best two quarters of growth we've had since the recession in 2008. tyler? >> you know, i have a quick question for you. i'm reading some of the prepared testimony or text from mr. fisher and he says i was pleased with the decision finally to begin tapering our bond purchases, though i would have preferred to pull back our purchases by double the announced amount. and i find it very interesting that the stock market basically has only lost about three points despite -- which is a somewhat more aggressive stance and he's a voting member this time. >> we have done some work on this and what we show is that the stock market tends to discount the views of hawks. their views on interest rates are substantially higher than

the center of the board, and their views have not been at the center of policy and have not created policy. so you listen to richard fisher, he's a smart guy, he has an opinion about fed policy that's at odds with the center we reported but it's well to point out that both he does not speak for really the center of the board and the market we have shown when it comes to forecasting what the fed funds rate will be, tends to discount the views of the three most hawkish members of the board. >> the market, if i'm understanding what you're saying, they put the hawks as the outliars, therefore, they're not going to influence policy. >> right. right. >> those that are of middle ground or perhaps in the past were somewhat undecided about whether or not to taper actually hold more sway with the market. >> right. the reason we made a big deal of fisher right now, he's sort of pledging his vote out further. pretty unusual. when we asked jeff lacquer, president of the richmond fed, what his point was, what his estimate was for the funds rate

of 2015, he describes himself as the third dot from the sun. which is a reference to those estimates that the fed puts out. so he's the third highest among them. so those are guys that basically tend to have much higher funds rates and when we calculate what the estimate is of the market in our fed survey, for where the fed will be, it matches up perfectly with the fed if we throw out the three hawks. >> that is fascinating. mr. plosser is included, because he spoke to. >> that's right. doesn't make him wrong, just makes they are outliers and the market tends to discount it. >> what did you make of mr. plosser's comments? he downplays the drop in the employment number we saw last week in terms of the numbers of new jobs created. he thinks maybe that was an outliar. i found that interesting and also, that he prefers a quicker than planned withdrawal of bond buying which seems to dovetail, no pun intended, with mr. fisher. >> well, the thing about

plosser, he doesn't want a quicker withdrawal of bond buy. he doesn't want any bond buying at all. what he really means is he would like to get rid of it but if we have to keep it, he wants it drawn down more quickly, as does fisher here. by the way, fisher also says -- treats the jobs report as a one-off which by the way, a lot of economists do as well. that seems to be pretty conventional wisdom now, there were a bunch of things that were positive when it came to jobs and there was the actual jobs report which was negative, and in lack of further evidence, they will believe what they saw before. >> steve, thanks for spending time with us. appreciate it. let's turn to some corporate news right now. time warner cable says no thanks to charter communications' takeover offer. cable stocks are all up today, as you can see. some by very significant percentage moves. as the industry consolidates, at what point does it become virtually impossible to make a deal that regulators are going to approve? plus, the target data breach putting the spotlight on the

cyberstocks. josh lipton is all over that for us. hi, josh. >> reporter: yeah, sue, hackers have been making news, stealing personal information. that can mean more business for some security vendors. i will tell you which ones when "power lunch" continues. are a . seeker of the sublime. you can separate runway ridiculousness... from fashion that flies off the shelves. and you...rent from national. because only national lets you choose any car in the aisle... and go. and only national is ranked highest in car rental customer satisfaction by j.d. power. (natalie) ooooh, i like your style. (vo) so do we, business pro. so do we. go national. go like a pro.

about the most track-tested is ever... but the truth is... we don't have to. the experts have spoken. now it's your move. ♪ when i first felt the diabetic nerve pain, of course i had no idea what it was. i felt like my feet were going to sleep. it progressed from there to burning like i was walking on hot coals... to like 1,000 bees that were just stinging my feet. i have a great relationship with my doctor... he found lyrica for me. [ female announcer ] it's known that diabetes damages nerves. lyrica is fda approved to treat diabetic nerve pain. lyrica is not for everyone.

it may cause serious allergic reactions or suicidal thoughts or actions. tell your doctor right away if you have these, new or worsening depression, or unusual changes in mood or behavior. or swelling, trouble breathing, rash, hives, blisters, changes in eyesight including blurry vision, muscle pain with fever, tired feeling, or skin sores from diabetes. common side effects are dizziness, sleepiness, weight gain and swelling of hands, legs and feet. don't drink alcohol while taking lyrica. don't drive or use machinery until you know how lyrica affects you. those who have had a drug or alcohol problem may be more likely to misuse lyrica. having less pain -- it's a wonderful feeling. [ female announcer ] ask your doctor about lyrica today. it's specific treatment for diabetic nerve pain. to hear more of phyllis's story, visit lyrica.com. welcome back to "power lunch." the dow is pushing toward its first really up day here in five sessions right now, leading the index higher, you got names like intel on a jpmorgan upgrade. also, microsoft, despite a

downgrade from citigroup this morning, citi holding its price target with a $35 level here. disney after taking a hit yesterday, 3m, travelers showing signs of strength here. again, the dow pushing higher thanks to those particular stocks. sue, back to you. let's take a look at the gold market right now, because we are approaching the close. sharon epperson is tracking that action for us. >> reporter: we are looking at gold prices down a few dollars but below the 1250 level and really, as we have seen equities rebound from the lows of yesterday, we are seeing pressure on gold prices. but it's very much a position of what's happening to the dollar as well. if you look at what has happened to the dollar and to the metals, we are seeing the dichotomy there as well. we're watching, too, some technical levels because many traders are saying that the gold move is going to really hinge on the technical momentum that we're seeing one way or the other in the gold price and whether or not we get back up to the december levels around 1267,

or whether we get back down to those lows near 1212. that's what we're looking at here in terms of the technical levels to breach in the gold market. back to you. >> very quickly, did we see any reaction to the two fed speakers? i didn't detect too much of a move in the gold market. >> reporter: there was not much of a move at all. the gold market has been pretty steady and quiet today. traders are watching those commentaries. >> sorry. we have to go. stay with us. the federal reserve is issuing what they call an advance notice of public proposed rule making to the public, essentially seeking input from banks and other members of the public on commodities and whether commodities among other things could pose a systemic risk if there was some sort of environmental catastrophe, injuries or even fatalities that resulted from some sort of commodity related activity. as examples of the type of thing that might happen and cause billions of dollars in losses to the companies involved, they list the deepwater horizon fire

from 2010 as well as the japanese nuclear meltdown as recent types of events that could potentially affect a bank that's involved in commodities. so very interesting. they posed 24 questions to the industry and to others and they are looking for feedback on whether they should change these rules to help safeguard the system. >> very interesting. sharon, that's your beat. what do you think about that? >> reporter: a lot of traders have been watching and of course, watching the risk management in the commodities sector based on what we saw with the deepwater horizon and the potential impact that something like that, if it were god forbid to happen again, could have on commodities prices. it will be interesting to see the commentary that comes in and what some of the banks have to say about it as well as what some of the industry players and policy makers have to say about this. but it is an interesting development. >> if i may, i found this provocative, too, because we were expecting to see out of the fed some questioning about the so-called complementary

authority where banks are allowed to hold physical commodities if it engages their trading business. but this is a much broader set of questions than that. the idea that a bank could be involved in some sort of disaster like this that causes, you know, a potentially soundness risk in terms of the liabilities and the tragedies involved, very interesting. they are obviously thinking about this on a much deeper level than i realized. >> i would agree with you completely, kate, because especially given the interconnections that we have in the markets now. it used to be the commodities and equities were very much distinct vehicles that banks would trade but it doesn't work that way anymore. >> no more. no more. >> it's going to be interesting to see how that plays out. ladies, thank you very much. appreciate it. target's data breach and other major hack attacks have corporate i.t. chiefs very worried, which publicly traded securities firms are smart bets for you to play in the cyberthreat atmosphere. josh lipton is tracking some of those for us. josh, over to you. >> reporter: yes, cybercriminals have been stealing personal

information in a wave of high profile attacks. that has chief information officers worried, which means more business for some security vendors. morgan stanley just released results of a survey of cios and found that network security does remain a high priority for them in 2014. executives expect an average of 8% growth in network security this year versus 6% last year. the recent hack attacks against target, neiman marcus, and skype have made it clear how serious this cyberthreat is. how can investors profit from this stronger demand for security in the new year? keith weiss at morgan stanley says one of his top picks is fortnet. the company just announced it will release q-4 results on january 29th. investors feel like results must be okay, he says, otherwise the company would have prereleased its numbers. and one will stick with fire-eye, saying it will take shares from mcafee and cisco

over the next few months. and webbush is bullish on infoblox. the pullback gives investors a chance to own a name which will play a big role in network security. sue, back to you. >> thank you very much. let's take a look at interest rates. we have the dow jones industrial average largely holding on to its earlier advance. we're up 79 points on the trading session after the drubbing we took yesterday. right now the ten-year note is trading at a yield of 2.87%. take a look at the 30-year. as bob pointed out to me yesterday, we may be seeing some pension funds move back into certain parts on the longer dated side of the treasury market because the yield there is just below the 4% mark, 3.80%. we're watching that one carefully. that's your bond report for today. ty? we are only ten trading days into what has so far been a rather bumpy 2014.

but this stock is already red-hot. it's up more than 30% so far this year. hitting new 52-week highs. the company's ceo will join us to explain why wall street is so smitten with his company right now. good place to be. ♪ [ bell ringing, applause ] five tech stocks with more than a 10%... change in after-market trading. ♪ all the tech stocks with a market cap... of at least 50 billion... are up on the day. 12 low-volume stocks... breaking into 52-week highs. six upcoming earnings plays... that recently gapped up. [ male announcer ] now the world is your trading floor. get real-time market scanning wherever you are with the mobile trader app. from td ameritrade. life's an adventure wand it always has been.pp. but your erectile dysfunction - it could be a question of blood flow. cialis tadalafil for daily use helps you be ready anytime the moment's right.

you can be more confident in your ability to be ready. and the same cialis is the only daily ed tablet approved to treat ed and symptoms of bph, like needing to go frequently or urgently. tell your doctor about all your medical conditions and medications, and ask if your heart is healthy enough for sexual activity. do not take cialis if you take nitrates for chest pain, as this may cause an unsafe drop in blood pressure. do not drink alcohol in excess with cialis. side effects may include headache, upset stomach, delayed backache or muscle ache. to avoid long-term injury, seek immediate medical help for an erection lasting more than 4 hours. if you have any sudden decrease or loss in hearing or vision, or if you have any allergic reactions such as rash, hives, swelling of the lips, tongue or throat, or difficulty breathing or swallowing, stop taking cialis and get medical help right away. ask your doctor about cialis for daily use and a 30-tablet free trial.

at a company that's bringing media and technology together. next is every second of nbcuniversal's coverage 0f the 2014 olympic winter games. it's connecting over one million low-income americans to broadband internet at home. it's a place named one america's most veteran friendly employers. next is information and entertainment in ways you never thought possible. welcome to what's next. comcastnbcuniversal. and truecar users... save time and money. so when you're... ready to buy a car, make sure you... never overpay.

visit truecar.com today. at this hour, we are watching broadband service providers like our parent company, comcast, at & t, verizon and content providers like netflix. federal appeals court striking down the fcc's open internet rules. the move could give broadband providers more room to charge content companies for faster speeds and delivery of that content. sue? >> exelis touching a fresh 52-week high right now. that biotech company receiving an upgrade last week. the firm upping its call to overweight from neutral. the stock is up 30% then. live and exclusive from san francisco is the company's president and ceo, dr. michael morrissey. nice to have you here. welcome. >> good morning. great to be here today. thank you. >> i know that you have a lot of exciting news with your company.

basically you have six late stage studies ongoing for several types of cancer, and a number of those results will be back in 2014. i would like to focus on, i hope i pronounce the name of this drug correctly or this molecule correctly, cometric. what makes you so confident that that is going to be a winner this time around for your company? >> well, again, we have been studying the drug cometric, its brand name, for literally the last ten years and the laboratory and early clinical trials, and now it's the subject of five individual late stage clinical studies. we have i think very interesting data across a spectrum of different types of cancer in early studies. certainly the prostate cancer trials are the ones that are the most important to us right now. in our early work, we've seen

very unique activity, very provocative data, and the goal of these two pivotal trials is to really confirm the activity in a randomized global trial and be able to move forward if successful. >> it's a crowded field, though. you have j & j and a number of other companies that came out with some very promising drugs as well, and the analysts i talked to said he would like to hear from you why you think this particular drug will be able to compete in what he called a very crowded space. >> well, it's a good point. there has been a lot of success in the area of prostate cancer over the last few years. there are five new approved therapies in prostate cancer. so a real resurgence in both clinical research, understanding of the prostate cancer disease. that's the good news. the bad news is that based upon data from the american cancer society, it's estimated that 30,000 men will die from

prostate cancer this year. that's a staggering number of men that will succumb to this disease in the face of all those new therapies. again, in early studies, we have seen very interesting data that really focuses on all the key components of this disease. we've documented that in several hundred patients and now are doing the key experiments in two different clinical trials to answer those key questions. >> doctor, any progress that you make on that front is good progress for everybody concerned. best of luck to you. thank you very much for joining us today. >> thanks again. coming up tonight on "mad money" with jim cramer, a trio of health care ceos. the chief executives of regeneron and walgreens and alkermes tonight on "mad money" at 6:00 p.m. eastern time. while the major averages are down so far in 2014, these three stocks are up. alkermes, 17% so far this year. that's coming up with jim later this afternoon. we just mentioned the dow and s&p are down so far this

year. but it's the nasdaq 100 you need to watch. what the nas 100 is saying about the year ahead. plus dominic chu on retail detail. dom? >> well, if you bet on the american consumer last year, it returned a healthy profit for you. but this time around, the holiday season, we saw a slowdown into this year, it's carrying through. we will take you to all the big losers in retail so far in 2014. >> see who steve cohen went to the knicks game with last night. back in two minutes. i have low testosterone. there, i said it. see, i knew testosterone could affect sex drive, but not energy or even my mood. that's when i talked with my doctor. he gave me some blood tests... showed it was low t. that's it. it was a number. [ male announcer ] today, men with low t have androgel 1.62% testosterone gel. the #1 prescribed topical testosterone replacement therapy increases testosterone when used daily. women and children should avoid contact with application s. discontinue androgel and call your doctor

if you see unexpected signs of early puberty in a child, or signs in a woman, which may include changes in body hair or a large increase in acne, possibly due to accidental exposure. men with breast cancer or who have or might have prostate cancer, and women who are or may become pregnant or are breast-feeding, should not use androgel. serious side effects include worsening of an enlarged prostate, possible increased risk of prostate cancer, lower sperm count, swelling of ankles, feet, or body, enlarged or painful breasts, problems breathing during sleep, and blood clots in the legs. tell your doctor about your medical conditions and medications, especially insulin, corticosteroids, or medicines to decrease blood clotting. in a clinical study, over 80% of treated men had their levels restored to normal. talk to your doctor about all your symptoms. get the blood tests. change your number. turn it up. androgel 1.62%.

two chums taking in a basketball game on monday night seems like an ordinary thing for people to do unless you happen to be the billionaire fund manager steve cohen and the top art gallery owner, larry degozian sitting courtside at a knicks game. the knicks beat the suns. then the twitterverse is in on the action as you see right

there. is it a sign that steve cohen is about to buy or sell some famous work of art? he owns a lot of it. emmy winning frontline producer martin smith, who recently made a pbs documentary about cohen, called "to catch a traitor" spotted the pair as he watched on tv, took the photo on his iphone and posted it on twitter. within seconds there were retweets and comments galore about the pair's nba outing, even one about cohen's sweater, proving once again somebody is always, always watching. let's see what's coming up on "street signs." >> that's why you can't go anywhere. you are so well known. you literally can't go to the grocery store. our theme, stocks, sharks and squids. our guests say they have picks they think are undervalued. you know you guys have a former contestant from "shark tank" coming up. we have a shark. and the video i promise that may keep you away from eating fried

calimari ever again. back to you guys on "power lunch." welcome back to the east coast, buddy. all right. let's talk more about this market which is now up 91 points. bob pisani is here at post nine joining me here at the nyse. so much for fed-speak. >> two hawks. i think steve liesman had the right comment on this. put up the s&p 500. we had mr. fisher, richard fisher, head of the dallas fed, saying it's important for the fed to press forward and end bond buying. no question there about where he stands. then charles plosser, head of the philly fed, saying future rate increases may have to be aggressive. two hawks, notice they didn't move the market. sue and i were talking about this. dennis lockhart yesterday, head of the atlanta fed, a moderate, came out and said he would support the tapering program, the market dropped. we had a comment earlier, steve saying hawks don't move the markets when they make hawkish statements as much as moderates do. i think that makes sense. that's the story of what's going

on. take a look at the dow industrials. one of the reasons we're up today is because they ran out of selling pressure. we simply had to move up at the open. they tried to sell off, you see that little droop right at the open, but when they stopped going down, the selling pressure declined. we saw a turnaround, volume picked up and it's been basically right near the highs for the day. retail sales numbers were okay, not great. most of the retailers are posting a mild turnaround today after a terrible start to 2014. >> they have not had a good 2014 so far. a little reprieve today. thank you. uptown now to seema, where the nasdaq's having a decent day. >> yeah, we're looking at the nasdaq now at session highs again. its large cap tech and biotech providing market leadership today. but that doesn't mean we don't have any losers for the year. investors have been booking profits on some of 2013's winners, including netflix, staples, bed, bath and beyond and whole foods and in the technology space, microsoft, ebay, apple, names that are up today, but they are still down on the year.

so those are names to keep in focus. there is also red-hot biotech providing leadership today. however, celgene an underperformer in 2014. those are some names that haven't had the best start to the year but speaking to douglas mclayne, they say this is simply profit booking and the long term story for biotech and tech is still favorable. back to you. >> i will take it. thank you very much, seema mody. holiday shopping sales figures, the final, the formal, the official ones are out. the national retail federation says sales in november and december rose 3.8% compared with the year prior. about $602 billion. i spent $601 billion of that. that's just shy of the nrf's -- mostly on you. on the nrf's 3.9% estimate. but sales did rise year over year, so which retailers are feeling the most pain heading out of the gate in 2014? pain? >> pain this time around because we were talking about how they were the best performers last year. take a look at this time around. black friday until the end of

the year in 2013, the holiday shopping season saw some pretty big losers as we saw names start to lose momentum on that retail trade. check out express at malls all over the country, down 24%. that stock. also, ulta beauty, health, hair, beauty products, that store down 24% in terms of its stock price. then there's embattled retailer sears, which no surprise here, it's been down for awhile but it was down 23% during the holiday season over that time frame. over the past couple weeks, we have heard a host of companies come out with their forecast to manage expectations surrounding perhaps lackluster holiday sales. sears again down 28% and that's just in the first two weeks of this year. again, some skepticism there about sears' future. also, fellow struggling retailer jc penney is down 27%. the seller of all things yoga, lululemon falling 16% and that's just since the year started. if you're an investor looking at bed, bath and beyond, you've got to wonder if there's help for the consumer as well.

that stock down 15%. if you're looking to make a bullish play on the consumer, you had to be selective with these stocks. some of them got hit really hard but stay tuned to the closing bell this afternoon because we will take you through some of the hottest retail plays out of the gate this year. sue, back to you. are you ready to swim with the sharks? "shark tank" returns on cnbc tonight, 8:00 p.m. eastern. tough self-made multi-millionaire and billionaire tycoons give budding entrepreneurs the chance to make their dreams come true and potentially secure business deals that could make them millionaires. we have a sneak peek in two minutes' time. customizable charts, powerful screening tools, and guaranteed one-second trades.

and at the center of it all is a surprisingly low price -- just $7.95. in fact, fidelity gives you lower trade commissions than schwab, td ameritrade, and e-trade. i'm monica santiago of fidelity investments, and low fees and commissions are another reason serious investors are choosing fidelity. call or click to open your fidelity account today. over the pizza place on chestnut street the modest first floor bedroom in tallinn, estonia and the southbound bus barreling down i-95. ♪ this magic moment it is the story of where every great idea begins. and of those who believed they had the power to do more. dell is honored to be part of some of the world's great stories. that began much the same way ours did. in a little dorm room -- 2713. ♪ this magic moment ♪

this will be a fun segment and a fun evening tonight because "shark tank" returns this evening on cnbc at 8:00 p.m. eastern time. for the first time, an entrepreneur who walked away from a deal returns to the tank and is given another chance to swim. swim at the american dream. that man is james martin, ceo of copadivino, second largest winery in oregon. his product, his novelty is wine by the glass. james, welcome. tell me about the product, how you came up with this idea. do you sell wine by the bottle also? or just by the glass? >> we have a premium winery but our focus is on wine by the

glass. the value to the consumer is you don't have to open a bottle, you have an easy -- >> can we zoom in here? let's open it together here. i'm going to channel my inner kathie lee and hoda. let's have a sip here. it's as simple as that. cheers. >> cheers. >> very nice to have you here. >> how's the wine? >> it's very nice. >> excellent. >> so this was your concept. what is it like being in the shark tank? when were you on the first time? >> the first time i was on was in 2011 and obviously, a lot of pressure. you've got an amazing amount of your life riding on the line, and these five sharks are very serious about business. the real value to the show to me is that everyone is an entrepreneur out there at home watching this. everyone has an idea of what they want to do. >> and you turned down their offer of capital. what was it, and why? >> they wanted to split the company in half so they wanted to take the patents away from the company. we wanted to grow our brand and

so very, very action-packed, very high pressure episode. in fact, i probably set a record for -- >> do you have to make a decision right there and then? >> absolutely. >> here's our offer -- >> yes. >> -- do you take it, do you not? >> exactly. >> you had to decide right then. how has the company been doing lately? >> we've had phenomenal growth. we've had what they call the "shark tank" effect. we have revenues of almost $25 million as a company in three years. >> wow. >> we are the winery of madison square garden. we've had, you know, we're in walmart. >> i was going to ask, you through stores, beverage stores, convenience stores, big as walmart. walmart likes you, that's a nice place to be. also in restaurants and places like stadiums where i can see this being a real, real convenience. >> yeah, madison square garden, their sales are up over 30%. radio city music hall, there's a lot of nfl locations where it's been fantastic.

>> that is really -- james, congratulations on your success. we will see you again tonight. i'm not going to give away what happens tonight or whether you take an offer or whether they even make one, but you will find out tonight, 8:00 p.m. and again at 12:00 a.m. eastern time on cnbc. james, congratulations. >> thank you. cheers again. >> to you, the same. two of the biggest -- we don't really care about etf winners. we're having some wine. we'll be right back. here. sorry to interrupt, i just want to say, i combined home and auto with state farm, saved 760 bucks. love this guy. okay, does it bother anybody else that the mime is talking? frrreeeeaky! [ male announcer ] bundle home and auto and you could save 760 bucks. alright, mama, let's get going. [ yawns ] naptime is calling my name. [ male announcer ] get to a better state. state farm.

while ty sips his wine, i will get you up to date on the markets. we're up 85 points on the dow jones industrial average. the s&p up 16 and the nasdaq composite is the winner percentage-wise, up 1.5% or 62 points. three dow winners today, intel, microsoft, and disney, all with really decent gains on a percentage basis. intel leading the way there. etf winners right now, the spider s&p retail etf, xrt energy select sector spider xle as well. all right. ty, i am jealous. you're still there. >> cabernet?

the sacrifices we make for our viewers. >> we always work for the viewers. cheers. >> we always work for the viewers. this is very delicious, by the way. we'll have a cabernet and crahdonnay for you when you get home. that does it for "power lunch." you see that "power lunch" sipping wine with their pinky in the air? "street signs," we taste whiskey. i'm just throwing that out there. stocks are overvalued. unless they're not. it is the hot debate on wall street. we are all over it. hi, everybody. here are the big stories today. why google made a $3 billion deal for a company that makes thermostats. is herb greenberg ready to throw in the towel on a name he has been all over? that stock is soaring today. and "shark